Bill Text: NJ A5935 | 2018-2019 | Regular Session | Introduced
Bill Title: Places cap of $100 on amount paid by covered persons for purchase of insulin.
Spectrum: Partisan Bill (Democrat 4-0)
Status: (Introduced - Dead) 2019-11-18 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A5935 Detail]
Download: New_Jersey-2018-A5935-Introduced.html
Sponsored by:
Assemblyman R. BRUCE LAND
District 1 (Atlantic, Cape May and Cumberland)
Assemblyman MATTHEW W. MILAM
District 1 (Atlantic, Cape May and Cumberland)
Assemblyman JOHN ARMATO
District 2 (Atlantic)
Co-Sponsored by:
Assemblyman Mazzeo
SYNOPSIS
Places cap of $100 on amount paid by covered persons for purchase of insulin.
CURRENT VERSION OF TEXT
As introduced.
An Act concerning prescription insulin coverage and supplementing P.L.1997, c.192.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. a. A carrier that provides coverage for prescription drugs pursuant to the terms of a health benefits plan offered by the carrier shall not require a covered person to pay, for a covered prescription insulin drug, an amount exceeding $100 per 30 day supply of insulin, regardless of the amount or type of insulin needed to fill the covered person's prescription.
b. Nothing in this section shall prevent a carrier from reducing a covered person's cost sharing by an amount greater than the amount specified in this section.
c. As used in this section, "prescription insulin drug" means articles that contain insulin and are used to treat diabetes, including:
(1) articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them;
(2) articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals;
(3) articles, other than food, intended to affect the structure or any function of the body of man or other animals; and
(4) articles intended for use as a component of any article specified in clause (1), (2), or (3).
"Prescription insulin drug" does not include biological products, or devices or their components, parts, or accessories.
2. This act shall take effect on the first day of the seventh month next following the date of enactment, but the Commissioner of Banking and Insurance may take such anticipatory administrative action in advance thereof as shall be necessary for the implementation of the act.
STATEMENT
This bill provides that carriers that provide coverage for prescription drugs pursuant to the terms of a health benefits plan offered by the carrier are prohibited from requiring a covered person to pay, for a covered prescription insulin drug, an amount exceeding $100 per 30 day supply of insulin, regardless of the amount or type of insulin needed to fill the covered person's prescription.
Places cap of $100 on amount paid by covered persons for purchase of insulin.
